Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Sinovac Biotech Ltd (SVA)

Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement Business Wire - Sun Jan 4, 9:13AM CST

Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua...

SVA : 6.47 (-0.31%)
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report Business Wire - Sun Jan 4, 9:00AM CST

Sinovac Biotech Ltd. (NASDAQ: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, today announced that it has received...

SVA : 6.47 (-0.31%)
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting Business Wire - Wed Dec 17, 2025

Sinovac Biotech Ltd. (NASDAQ: SVA) ( SINOVAC or the Company ), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered...

SVA : 6.47 (-0.31%)
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal Business Wire - Tue Nov 18, 2025

Sinovac Biotech Ltd. (Nasdaq: SVA) (“ SINOVAC ” or the “ Company ”), a leading provider of biopharmaceutical products in China, announced today that on November 12,...

SVA : 6.47 (-0.31%)
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment PR Newswire - Tue Nov 11, 2025

BOSTON , Nov. 11, 2025 /CNW/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent Sinovac shareholders...

SVA : 6.47 (-0.31%)
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment PR Newswire - Tue Nov 11, 2025

BOSTON , Nov. 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Silk Road Investments LLC today announced that it has heard from more than 100 independent Sinovac...

SVA : 6.47 (-0.31%)
Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share Newswire.ca - Thu Apr 10, 2025

/CNW/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Partners, LLC sent a letter on April 8, 2025, to Sinovac's Board calling on the Board to...

SVA.TO : 0.1250 (-3.85%)
SVA : 6.47 (-0.31%)
Heng Ren Partners Demands Sinovac Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading Newswire.ca - Thu Mar 20, 2025

/CNW/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's...

SVA.TO : 0.1250 (-3.85%)
SVA : 6.47 (-0.31%)
SINOVAC Reports Unaudited Second Half of 2022 Financial Results and Files 2022 Annual Report on Form 20-F Business Wire - Mon May 1, 2023

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities...

SVA.TO : 0.1250 (-3.85%)
SVA : 6.47 (-0.31%)
Sinovac Amends Shareholder Rights Plan Business Wire - Wed Feb 22, 2023

Sinovac Biotech Ltd. (“Sinovac” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder...

SVA.TO : 0.1250 (-3.85%)
SVA : 6.47 (-0.31%)

Barchart Exclusives

CES 2026, Sector Rotation and Other Key Things to Watch this Week Barchart - Sun Jan 4, 12:00PM CST
Markets enter 2026's first full trading week with an extraordinary convergence of events including the Consumer Electronics Show (CES) in Las Vegas where Nvidia CEO Jensen Huang and AMD CEO Lisa Su will deliver keynote speeches that could significantly influence AI infrastructure investment narratives Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot